In the development of prostate cancer, cell survival is dependent on androgens and androgen receptors, therefore, androgen deprivation therapy (ADT) combined with anti-androgen therapy is widely used in prostate cancer treatment (5). The gene discussed is AR; the disease is prostate carcinoma.